Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 4 of 22, showing 5 Applications out of 106 total, starting on record 16, ending on 20

# Protocol No Study Title Investigator(s) & Site(s)

16.

ECCT/22/05/02   BREATHER Plus
        A randomised open-label 2-arm, 96-week trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir-based triple antiretroviral therapy (ART) compared to daily dolutegravir/tenofovir-based triple ART in virologically suppressed HIV-infected adolescents aged 12 to 19 years of age in sub-Saharan Africa   
Principal Investigator(s)
1. Abraham Siika
Site(s) in Kenya
Moi University Clinical Research Centre
 
View

17.

ECCT/22/03/07   ELEVATUM
    A PHASE IIIB/IV, MULTICENTER, OPEN-LABEL, SINGLE-ARM STUDY TO INVESTIGATE FARICIMAB (RO6867461) TREATMENT RESPONSE IN TREATMENT-NAÏVE, UNDERREPRESENTED PATIENTS WITH DIABETIC MACULAR EDEMA   
Principal Investigator(s)
1. Dr. Oscar Muwale Onyango
2. Dr. Muchai Gachago
Site(s) in Kenya
1. The Nairobi Hospital (Nairobi City county)
2. City Eye Hospital (Nairobi City county)
 
View

18.

ECCT/22/03/05   CHAPATI
    CHildren treated with vincristine: A trial regarding Pharmacokinetics, DNA And Toxicity of targeted therapy In pediatric oncology patients.   
Principal Investigator(s)
1. FESTUS MUIGAI NJUGUNA
Site(s) in Kenya
Moi Teaching and Referral Hospital
 
View

19.

ECCT/21/12/04   FAST Study
    Assessments of the EFficacy, the onset-of-Action and the Safety of Tot'héma® in adults with moderate iron deficiency anaemia   
Principal Investigator(s)
1. Dr. Francis Xavier Otieno Odawa
Site(s) in Kenya
1. MOI University Teaching and Referral Hospital (Nandi county)
2. UNIM Research and Training Centre (Kisumu county)
3. Kenyatta National Hospital (Nairobi City county)
 
View

20.

ECCT/21/12/02   The WHO ACTION Trial
    ACTION III: A multi-country, multi-centre, three-arm, parallel group, double-blind, placebo-controlled, randomized trial of two doses of antenatal corticosteroids for women with a high probability of birth in the late preterm period in hospitals in low-resource countries to improve newborn outcomes   
Principal Investigator(s)
1. Frederick Namenya Were
2. John Kinuthia
3. Zahida Parveen Qureshi
Site(s) in Kenya
1. Coast General Teaching and Referral Hospital (Mombasa county)
2. Thika Level 5 Hospital (Kiambu county)
3. Nakuru Level 5 Hospital (Nakuru county)
 
View